MSB 3.76% $1.03 mesoblast limited

Ann: FDA Supports Accelerated Approval Pathway for Heart Failure, page-296

  1. 30,257 Posts.
    lightbulb Created with Sketch. 1817
    partners will be the way to go, Silviu foreshadowed this a long time ago and has been consistent on that message.
    The point being that as we are so close to approval, partnerships will be more realistic and not cheap offers.
    The work can be done on partnership agreements, conditional on FDA approval, which means when the approvals come through it will all be in place.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.03
Change
-0.040(3.76%)
Mkt cap ! $1.170B
Open High Low Value Volume
$1.08 $1.09 $1.03 $7.869M 7.571M

Buyers (Bids)

No. Vol. Price($)
1 16411 $1.03
 

Sellers (Offers)

Price($) Vol. No.
$1.03 3952 2
View Market Depth
Last trade - 16.10pm 06/06/2024 (20 minute delay) ?
Last
$1.03
  Change
-0.040 ( 3.65 %)
Open High Low Volume
$1.07 $1.08 $1.03 1907057
Last updated 15.59pm 06/06/2024 ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.